This site is intended for health professionals only

Published on 25 June 2007

Share this story:
Twitter
LinkedIn

Trial backs Cycloset safety profile

teaser

A significant reduction in the risk of diabetic cardiovascular complications has been noted in subjects with type 2 diabetes treated with Cycloset



Most read




Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Share this story:
Twitter
LinkedIn